GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fabino Life Sciences Ltd (BOM:543444) » Definitions » Gross-Profit-to-Asset %

Fabino Life Sciences (BOM:543444) Gross-Profit-to-Asset % : 9.70% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Fabino Life Sciences Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Fabino Life Sciences's annualized Gross Profit for the quarter that ended in Mar. 2024 was ₹11.3 Mil. Fabino Life Sciences's average Total Assets over the quarter that ended in Mar. 2024 was ₹116.3 Mil. Therefore, Fabino Life Sciences's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 9.70%.


Fabino Life Sciences Gross-Profit-to-Asset % Historical Data

The historical data trend for Fabino Life Sciences's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fabino Life Sciences Gross-Profit-to-Asset % Chart

Fabino Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial 10.29 11.07 18.08 8.51 10.09

Fabino Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial - 9.37 8.70 14.35 9.70

Competitive Comparison of Fabino Life Sciences's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Fabino Life Sciences's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fabino Life Sciences's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fabino Life Sciences's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Fabino Life Sciences's Gross-Profit-to-Asset % falls into.



Fabino Life Sciences Gross-Profit-to-Asset % Calculation

Fabino Life Sciences's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=10.279/( (50.107+153.568)/ 2 )
=10.279/101.8375
=10.09 %

Fabino Life Sciences's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=11.288/( (79.114+153.568)/ 2 )
=11.288/116.341
=9.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Fabino Life Sciences Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Fabino Life Sciences's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Fabino Life Sciences (BOM:543444) Business Description

Traded in Other Exchanges
N/A
Address
Murthal Road,, Shubham Garden, Jeevan Vihar Extension Near, Sonipat, HR, IND, 131001
Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.

Fabino Life Sciences (BOM:543444) Headlines

No Headlines